Take a closer look at the latest developments in stem cell research in 2016
Stem cells have experienced rapid development in the last decade, from embryonic stem cells to adult stem cells, further to ips and their application in animal experiments and clinical applications, from small-scale clinical research to the market launch of some stem cell products, undoubtedly for future clinical applications. Provides huge imagination. As progenitor cells of various tissue cells in the human body, stem cells are expected to play an important role in almost all major human diseases in the future. In addition to broad application prospects, stem cell therapy is more important in 2016 to face multiple “resonances†of global and domestic catalysts. The application of stem cell therapy is promising. Global stem cell drugs and policies are expected to make breakthroughs in the next two years. It is estimated that there will be about 400 billion US dollars in the world by 2020. The following small series takes you back to the latest developments in recent stem cell research: 1. On October 11, 2016, in a new study, Japanese researchers made significant progress in achieving organ regeneration: using the stem cells produced by monkey skin cells to regenerate the damaged heart of five diseased macaques. The relevant research results were published online in the journal Nature on October 10, 2016, and the title of the paper is "Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts". The experiment is expected to achieve treatment by transplanting a non-controversial large regenerative cell into a heart patient. The author of the paper, Yuji Shiba, a scientist at Shinshu University in Japan, said, "We still have some obstacles, including the risk of tumor formation, arrhythmia and cost." But it is undeniable that this is a major technological breakthrough. 2. Researchers from the Karolinska Institute in Sweden identified dopamine-producing cells in the midbrain of mice and humans and developed a method to assess the quality of dopamine-producing cells cultured in vitro. The study of Jinsen disease has great benefits. The results of the study were published in the Cell Journal on October 6, 2016, entitled "Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells." The symptoms of Parkinson's disease are caused by the loss of cells producing dopamine in the midbrain, which leads to the deterioration of motor function. There are no methods to treat this disease so far, but researchers are eager to replace the lost dopamine-producing cells with new cells produced by stem cells in the laboratory. Concentrated Extract Powder,Proportional Extract,Extractum,Concentrated Powder Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyibiology.com.jpg)
.png)
.png)